Design and participants
diabetic, T2DM, allergic
BREAST CANCER
This study included patients with T2DM aged 40–75 years old who were referred to Motahari hospital in Shiraz city, Iran. The patients were considered diabetic if they had an FBS level of 126 mg/dL or higher or were taking glucose-lowering agents or insulin injections. They were not allowed to participate if they were pregnant, lactating, using hormone replacement therapy, drinking alcohol, or smoking cigarettes. Additionally, we did not include people with breast cancer, allergic to soy milk or cow's milk, and people who took antibiotics three weeks before or during the study period. A patient who consumed food or products containing probiotic bacteria three weeks before or during the study period, who changed the dosage of oral antidiabetic drugs, insulin therapy or lipid-lowering drugs, or who did not follow the recommended diet, was excluded from study.The sample size for this study was calculated based on the results of a previously published study (n = 